Biomodulatory Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Study of Imatinib with Pioglitazone, Etoricoxib, Dexamethasone and Low-Dose Treosulfan-Reference-Cited by-同舟云学术

Biomodulatory Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Study of Imatinib with Pioglitazone, Etoricoxib, Dexamethasone and Low-Dose Treosulfan

Published:2014-12-11 Issue:1 Volume:8 Page:33-41
ISSN:1875-2292
Container-title:Cancer Microenvironment
language:en
Short-container-title:Cancer Microenvironment

Author:

Vogelhuber M.,Feyerabend S.,Stenzl A.,Suedhoff T.,Schulze M.,Huebner J.,Oberneder R.,Wieland W.,Mueller S.,Eichhorn F.,Heinzer H.,Schmidt K.,Baier M.,Ruebel A.,Birkholz K.,Bakhshandeh-Bath A.,Andreesen R.,Herr W.,Reichle A.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s12307-014-0161-7.pdf

Reference39 articles.

1. Ryan CJ, Smith MR, de Bono JS et al (2013) Abiraterone in metastatic prostate cancer without previous chemotherapy. N Engl J Med 368(2):138–148

2. Osanto S, Van Poppel H (2012) Emerging novel therapies for advanced prostate cancer. Ther Adv Urol 4:3–12

3. Hurwitz M, Petrylak DP (2013) Sequencing of agents for castration-resistant prostate cancer. Oncology (Williston Park) 27(11):1144–1149, 1154–8

4. Reichle A, Vogt T (2008) Systems biology: a therapeutic target for tumor therapy. Cancer Microenviron 1:159–170

5. Jain G, Cronauer MV, Schrader M et al (2012) NF-κB signaling in prostate cancer: a promising therapeutic target? World J Urol 30:303–310

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peroxisome proliferator-activated receptorα/γ agonist pioglitazone for rescuing relapsed or refractory neoplasias by unlocking phenotypic plasticity;Frontiers in Oncology;2024-01-11

2. Addressing Genetic Tumor Heterogeneity, Post-Therapy Metastatic Spread, Cancer Repopulation, and Development of Acquired Tumor Cell Resistance;Cancers;2023-12-29

3. Etoricoxib-Cannabidiol Combo: Potential Role in Glioblastoma Treatment and Development of PLGA-Based Nanoparticles;Pharmaceutics;2023-08-09

4. Biomodulatory therapy induces durable remissions in multi-system Langerhans cell histiocytosis;Leukemia & Lymphoma;2022-07-12

5. Drug Repurposing by Tumor Tissue Editing;Frontiers in Oncology;2022-06-24